Key funding to help lessen the spread of HIV in Austin could be affected as part of the federal Department of Government Efficiency's funding cuts at the Centers for Disease Control and the Prevention ...

The future of HIV care requires balancing scientific advancement with practical implementation. Long-acting antiretroviral ...

In a study published in AIDS Research and Therapy, Ph.D. candidate Thinh Vu explores the temporal trends in the time from HIV diagnosis to the initiation of antiretroviral therapy (ART) across the ...

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...

Study findings provide a new gene pathway for potential treatment of the virus affecting millions. Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the ...

Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.

Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...

Here authors describe the pathways that are governing these ... and the TLR7 agonist vesatolimod in men living with HIV-1. While the treatment showed a good safety profile and induction of HTI ...

might represent an important additional strategy for the treatment of HIV infection in the era after HAART therapy has been applied.

The three primary prevention strategies Dr. Maya outlines create a comprehensive approach to HIV prevention and treatment: First, regular screening has become more accessible than ever ...